Navigation Links
Shire Continues to Deliver Excellent Growth From Core Products
Date:10/30/2009

his role he had responsibility for GSK's pharmaceutical operations in the United States, Europe, Japan and all other International Markets. Mr Stout was also responsible for global manufacturing and global Biologics (vaccines) at GSK.

The Shire Board also announces that Mr David Mott will be stepping down from the Shire Board on the expiry of his term of office on October 30, 2009.

Matt Emmens, Chairman of Shire commented;

"We are delighted to welcome David Stout to the Shire Board. He brings with him extensive international experience in the pharmaceutical industry, which we believe will be of great value to Shire as it continues its growth trajectory and becomes a more global company.

We would also like to thank David Mott for his valuable contribution to the Shire Board over the last few years."

Dial in details for the live conference call for investors 14:00 GMT/ 10:00 ET on October 30, 2009:

    UK dial in: 0800-077-8492 or 0-1296-311-600
    US dial in: 1-866-804-8688 or 1-718-354-1175
    International dial in: +44(0)1296-311-600

    Password/Conf ID: 891 799#

    Live Webcast: http://www.shire.com/shire/InvestorRelations/index.jsp?tn=2
    OVERVIEW OF FINANCIAL RESULTS
    1. Introduction
    Summary of Q3 2009

Revenues from continuing operations for the three months to September 30, 2009 decreased by 14% to $667.0 million (2008: $778.6 million), due to the decline in branded ADDERALL XR product sales in Q3 2009 following the launch of an authorized generic version by Teva in April 2009. However, core product sales increased by 20% to $531.6 million (2008: $443.8 million).

Non GAAP operating income for the three months to September 30, 2009 decreased by 52% to $133.6 million (
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... HYDERABAD, India , July 31, 2015 /PRNewswire/ ... Billing and CRM solutions for video, data and cloud ... (PoC) with a leading pharma giant for Internet ... managing different IoT applications offered on subscription model. ... Pharma giant is striving for business ...
(Date:7/30/2015)... DIEGO , July 30, 2015 /PRNewswire/ ... it has signed a definitive agreement to ... of non-invasive ventilation and sleep-disordered breathing medical ... clinical, innovation and market reputation in China, combined with ResMed,s global leadership in ... people in China ...
(Date:7/30/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® and t:flex™ Insulin Pumps, today ... Agreements with Dexcom, Inc. to allow the integration ... Dexcom G5 and G6 continuous glucose monitoring ("CGM") ... platform with Dexcom,s future CGM systems is an ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... , , , , ... i c , Inc. (Nasdaq: ... medical imaging systems and surgical products dedicated to serving the healthcare needs ... study evaluating the impact of fetal fibronectin (fFN) testing among both symptomatic ...
... VIENNA, Va., Aug. 18 CEL-SCI Corporation (NYSE Amex: ... of its work towards creating a novel treatment and vaccination against ... in which the virus has acquired greater morbidity and mortality. ... are highly conserved and essential for the virus, survival. This ...
Cached Medicine Technology:Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 2Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 3Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 4CEL-SCI Expands H1N1 Flu Virus Work 2CEL-SCI Expands H1N1 Flu Virus Work 3
(Date:7/31/2015)... ... July 31, 2015 , ... ... announce that their latest designer handbag line will be named for Madeline Stuart, ... sensation as the first globally recognized model with Down syndrome, gracing the front ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... has announced plans to release a newly redesigned website at Healthpointe.net. The new ... enhanced user experience. , The redesign serves to provide smoother interactions between ...
(Date:7/31/2015)... ... , ... ZH Healthcare announces a new cloud based service delivering Health IT ... a Service (HITaaS) is a Healthcare dedicated cloud based service that sits over infrastructure ... manages all aspects of infrastructure, security, runtime, middleware, OS, virtualization, Servers, storage, contracts, ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... Medicine Practice, and Hospital Medicine Practice, is pleased to announce that it has ... mobile application format available on iPhones, iPads, and Android smartphones and tablets. ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The Radiology ... Michael Burgess, MD, (R-Tex) presenting “What’s Next for Health Care: A View From Capitol ... and founder of the Congressional Health Caucus, Rep. Burgess has a special understanding of ...
Breaking Medicine News(10 mins):Health News:everMaya to Launch Madeline Stuart Handbag Line 2Health News:everMaya to Launch Madeline Stuart Handbag Line 3Health News:Healthpointe Announces Newly Redesigned Website 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3
... Provides Best-of-Suite Technology, Streamlines ... ... Oct. 23 ,Medsphere Systems Corporation and Keane, Inc. today announced ... integrated best-of-suite clinical and financial software. The alliance,leverages Medsphere,s OpenVista(R) ...
... Palmetto GBA, a leading,provider of technical and administrative ... selected as a subcontractor as part,of a contract awarded ... for information technology modernization. Palmetto GBA is part ... for the unrestricted portions of CMS, Enterprise System,Development (ESD) ...
... incentives to health workers in low-income countries may hold the ... young children, according to a study published on bmj.com ... expert panel as one of eight of the most outstanding ... policy and will be presented at the launch of the ...
... Brings Additional Key Gene Locus as a ... for Recently-Funded Company, NEW HAVEN, Conn., Oct. 23 ... diagnose dry and wet Age-related Macular,Degeneration (AMD) and other ... it has licensed from the University,of Pittsburgh the worldwide ...
... Oct. 23 GeneGo, Inc., a leading,provider of ... they have licensed their MetaCore Data Mining Suite ... novel GeneGo,disease enrichment and functional ontology. MetaCore has ... the unique ability to concurrently,visualize gene expression, proteomics, ...
... designed to connect healthcare communities throughout ... ... During the World of,Health IT Conference and Exhibition today in Vienna, ... broad expansion of the Microsoft Healthcare Users Group (MS-HUG) to,partners and ...
Cached Medicine News:Health News:Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems 2Health News:Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems 3Health News:Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems 4Health News:Palmetto GBA Selected as Subcontractor for CMS' Enterprise System Development Project 2Health News:Financial incentives may hold key to cutting child malaria deaths 2Health News:Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations 2Health News:Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations 3Health News:GeneGo Licenses MetaCore Data Analysis Suite to AVEO Pharmaceuticals 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 3Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4
For the quantitative in vitro determination of Microalbumin in human urine....
Determination of Reptilase Time.Extracted venom of Bothrops atrox. 20 BU (Batroxobin unit) per vial....
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Activated Partial Thromboplastin Time (APTT) by STA Analyzers. Cephalin reagent with particulate (silica) activator....
Medicine Products: